Prospective Unmasked Randomized Evaluation of the iStent Inject® Versus Two Ocular Hypotensive Agents in Patients With Primary Open-Angle Glaucoma

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s59932
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Informa UK Limited

Related search

A Prospective Comparison of Chronic Primary Angle-Closure Glaucoma Versus Primary Open-Angle Glaucoma in Singapore

Singapore Medical Journal
Medicine
2013English

Factors Influencing the Placebo Effect in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: An Analysis of Two Randomized Clinical Trials

PLoS ONE
Multidisciplinary
2016English

Hypotensive Efficacy of Bimatoprost in Monotherapy of Primary Open-Angle Glaucoma

Vestnik Oftalmologii
MedicineOphthalmology
2018English

Ocular Blood Flow and Systemic Blood Pressure in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2004English

Increased Erythrocyte Aggregation in Patients With Primary Open Angle Glaucoma

Clinical and Experimental Optometry
OphthalmologyOptometry
2016English

Hepcidin Prohormone Levels in Patients With Primary Open-Angle Glaucoma

Open Journal of Ophthalmology
2014English

Effect of Mean Ocular Perfusion Pressure on Primary Open Angle Glaucoma

Bangabandhu Sheikh Mujib Medical University Journal
2018English

Distinct Iris Gene Expression Profiles of Primary Angle Closure Glaucoma and Primary Open Angle Glaucoma and Their Interaction With Ocular Biometric Parameters

Clinical and Experimental Ophthalmology
MedicineOphthalmology
2016English

Prm43 - A Cost-Utility Analysis of the Istent Inject Trabecular Micro-Bypass System Plus Cataract Surgery in Patients With Mild-To-Moderate Open-Angle Glaucoma in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy